Speech-Language Pathologists in Clinton, WA Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Amory Law Cable, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8175 Sandy Hook Dr, Clinton, WA 98236 Phone: 425-923-5844 |
 Brittany Olsen-boblitt, Ms, Ccc-slp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6210 Windfall Rd, Clinton, WA 98236 Phone: 206-409-6639 Fax: 360-641-7322 |
Brittany Ann Olsen-boblitt, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6210 Windfall Rd, Clinton, WA 98236 Phone: 206-409-6639 Fax: 360-641-7322 |
News Archive
Physicians say thyroid surgery safe for older people
Thyroid surgery is safe for older patients, say physicians who found only slight differences in rates of complications and hospital readmissions in a multi-year study.
FDA strengthens and modernizes postmarket drug safety program
A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration's oversight of drugs once they reach the American public, according to a new report released today by the agency's Center for Drug Evaluation and Research.
Okayama University e-Bulletin highlights role of designer DNA-binding proteins to fight viral infections in agriculture, medicine
This issue includes a feature on designer DNA-binding proteins to combat viral infections in agriculture and medicine; news items include updates of official opening of the Okayama University Silicon Valley Office at Fremont (CA), and international collaboration work with Xiamen University; research highlights on immunizing plants; identification of gene Vrn-D4 for enabling wheat to adapt to areas with warm winters; importance of introgression on intra-specific genetic differentiation and adaptive divergence; an interesting twist on supercooled liquid water; and manufacturing denim in Okayama.
Matching the right tumor with the right drug
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Data omission in widely used pesticides may have adversely impacted public health
For nearly 50 years, a statistical omission tantamount to data falsification sat undiscovered in a critical study at the heart of regulating one of the most controversial and widely used pesticides in America.
› Verified 3 days ago